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The effect of phorbol myristate acetate (PMA) was compared with that of histamine on the guinea-pig lung 
parenchymal strip. PMA, 10e5 M, caused a slowly developing sustained contraction which had approxi- 
mately the same magnitude as the maximal histamine contraction. Isoprenaline, at 10-S M, caused 86% 
relaxation of the histamine contraction but only 22% relaxation of the PMA contraction. Forskolin, at low5 
M had a similar action to isoprenaline on the effects of both spasmogens while aminophylline, 5 x 10m4 M, 
was considerably less effective. Sodium nitroprusside had little effect on the histamine contraction and actu- 
ally increased the PMA spasm. It is suggested that protein kinase C may have a role in the tonic phase 
of the contraction of bronchiolar smooth muscle. These findings could have relevance for the delayed phase 
of asthma, which is known to be insensitive to fl-agonists. 
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1. INTRODUCTION rabbit vascular smooth muscle [7,8]. 
There is increasing evidence that in cells in which 
calcium is an intracellular messenger, an early 
event following receptor stimulation is breakdown 
of polyphosphoinositides with generation of 
diacylglyceryol, which activates protein kinase C, 
and inositol trisphosphate, which mobilizes 
calcium (reviews in [1,2]). Recent findings suggest 
that this process may be involved in signal 
transduction in smooth muscle. Inositol trisphos- 
phate releases calcium from intracellular stores in 
skinned muscle fibres from porcine arteries [3] and 
turnover of polyphosphoinositides occurs during 
stimulus-activation coupling in guinea-pig ileal 
smooth muscle [4,5] and in canine tracheal muscle 
[6]. The involvement of the protein kinase C 
pathway is indicated by the fact that PMA has 
been found to cause tonic contraction in rat and 
Abbreviations: PMA, phorbol myristate acetate; 
DMSO, dimethyl sulphoxide 
Since a sustained contraction of bronchiolar 
smooth muscle is implicated in the pathogenesis of 
asthma we thought it of interest to investigate the 
effect of PMA on the lung parenchymal strip and 
to compare its effects with that of histamine, 
which, released from mast cells, is considered by 
many to be an important mediator of bronchial 
constriction in asthma. In the guinea-pig, 
histamine is present within the granules of the mast 
cell in a concentration of approx. 0.2 M. When the 
mast cell releases its contents after an antigen/an- 
tibody reaction it will produce a very high local 
concentration of histamine, likely to be of the 
order of 10-5-10-4 M - a concentration which 
could be expected to result in a maximal or near- 
maximal contraction of the bronchiolar smooth 
muscle in the vicinity. We set out to reproduce in 
vitro the effect of such histamine release, then to 
determine the concentratjon of PMA which pro- 
duced an equivalent contraction and then to com- 
pare the characteristics of the two responses. We 
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also thought it of interest to examine the effect of 
the &receptor agonist, isoprenaline, on both the 
histamine-mediated and the PMA-mediated 
response and to compare its effects with agents 
which acted at a post-receptor’ level to increase 
cyclic AMP levels (forskolin, aminophylline) or 
cyclic GMP levels (sodium nitroprusside). fl- 
Adrenoceptor .agonists and aminophylline are used 
in the treatment of asthma. 
2. MATERIALS AND METHODS 
Male Hartley guinea-pigs (350-400 g) were 
used. Parenchymal strips were cut from the distal 
edges of the lung lobes [9] and suspended under 
0.5 g tension in either 5 ml or 50 ml baths in 
Krebs-Henseleit solution, maintained at 37°C and 
aerated with 95% 02 and 5% COZ. Contractions 
were measured isotonically using UFI transducers 
(Lab-Data Instruments) and Servo Scribe Pen 
recorders (Services UK). 
Tissues were incubated in the organ baths for 
1 h before use. Contractions to histamine were ob- 
tained using concentrations of 10e6 M followed by 
lo-’ M, leaving the drug in the bath until the max- 
imum response occurred. PMA was added to the 
bath to give a final concentration of lo-’ M and 
was left in the bath for a minimum of 2 h to allow 
the contraction to reach maximum. The PMA was 
made up in DMSO and the final concentration of 
DMSO in the bath did not exceed 0.1%. At this 
concentration DMSO did not cause contraction or 
result in inhibition of either PMA or histamine 
responses. It is not possible to use an isometric 
recording technique with lung parenchymal strip 
preparations since the tissue is too delicate, and 
thus it is not possible to express a contraction in 
terms of g of tension. PMA-induced contractions 
were therefore expressed as % of the maximum 
histamine response. 
The reagents used were histamine acid 
phosphate, isoprenaline sulphate, theophylline 
ethylene diamine (aminophylline) and sodium 
nitroprusside (all obtained from Sigma,’ England) 
and forskolin (obtained from Calbiochem, 
England). 
The composition of the Krebs-Henseleit solution 
was as follows (gel-‘): NaCl, 6.9; KCl, 0.35; 
MgS04 - 7H20, 0.29; KH2P04, 0.16; NaHCO3, 
2.1; glucose, 2.0; CaC12, 0.55 (all chemicals being 
from BDH, England). 
3. RESULTS 
The mean normalized results of 20 experiments 
are given in fig. 1. Since normalizing and averaging 
results does not give a clear picture of the original 
data, examples of the results of individual ex- 
periments are given in fig.2. 
Addition of histamine to the lung parenchymal 
strip caused an immediate contraction, the max- 
imum response occurring with lo-’ M. PMA 
caused a slowly-developing sustained contraction 
(fig.2) which was concentration-dependent over 
the range 3 x 1O-8-1O-5 M. The concentration of 
10m5 M was selected for the experiments reported 
here since it gave approximately the same 
magnitude of contraction as the maximum 
histamine response. In 20 strips (from 10 guinea- 
pigs) this contraction was 112% (SE 6.4%) of the 
maximum histamine response. It took between 2 
and 3 h to reach maximum and washing the tissue 
,ool n-20 
- 
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Fig.1. The change in the histamine-induced and the 
PMA-induced contraction of the guinea-pig 
parenchymal lung strip obtained with various relaxants. 
The change is expressed as % relaxation or % increase 
of the maximum contraction given by histamine, 10m5 M
(hatched columns) or PMA, lo-’ M (doubly hatched 
columns). The ‘relaxants’ used were isoprenaline 
10m6 M; forskolin, 10e6 M; aminophylline, 5 x 10m4 M; 
and sodium nitroprusside, 10v5 M. The PMA 
contraction was 112% (SE 6.4%) of the maximum 
histamine contraction (n = 20). The bars represent 
standard errors. 
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Fig.2. Examples of records obtained with guinea-pig 
lung parenchymal strips, showing the cumulative dose- 
response curve with histamine (H), the contractile 
response to phorbol myristate acetate 10m5 M (PMA), 
and the relaxant effects of various agents. (The relaxant 
effect of isoprenaline was included in all experiments, as 
a standard.) The bar underneath the record of the PMA 
response represents the length of time PMA was left in 
the bath before the first addition of a relaxant; this was 
2 h 10 min in the upper record and 3 h 50 min in the 
lower. The bar above the contraction tracing in the 
upper record represents 30 min. Upper record: 
comparison of the effect of isoprenaline and forskolin 
on the H- and PMA-induced contractions. Lower 
record: comparison of the effect of isoprenaline on the 
H-induced contraction with the effect of isoprenaline, 
aminophylline and sodium nitroprusside on the PMA- 
induced contraction. Hl, 10e6 M histamine; H2, 10m5 M 
histamine; Ip, 10T6 M isoprenaline; for, 10T6 M 
forskolin; Nitropr, 10m5 M sodium nitroprusside; Am, 
aminophylline. 
did not decrease the contraction. In fact there was 
frequently an increase in tone when a strip was 
washed, and in the 10 strips in which the experi- 
ment was continued for an additional 40-60 min, 
the response gradually increased from 108% (SE 
9.0%) of the histamine maximum to 134% (SE 
11.3%) even though the strips were washed 
repeatedly. 
Both the histamine-induced and the PMA- 
induced contraction required the presence of 
calcium in the surrounding fluid. 
Since it was possible that histamine, released 
from mast cells by the PMA, couid have been con- 
tributing to the PMA-induced muscle contraction, 
and since the effect of histamine, but not that of 
PMA, disappeared on washing, most parenchymal 
strips were washed with Krebs-Henseleit solution 
before the effect of the relaxants was tested on the 
PMA contraction. 
Isoprenaline, 10e6 M, caused a rapid and vir- 
tually complete relaxation of the histamine- 
induced contraction (figs 1,2a and b) as did for- 
skolin, 10m6 M (figs 1 and 2a). However, 
isoprenaline, 10V6 M, had relatively little effect on 
the PMA-induced contraction (figs 1,2a and b). 
Forskolin, 10m6 M, a concentration which had ap- 
proximately the same effect as isoprenaline on the 
histamine contraction, also had relatively little ef- 
fect on the PMA contraction (figs 1 and 2a). If for- 
skolin, 10s6 M, was given before PMA, it marked- 
ly inhibited the subsequent response to PMA, 
10s5 M, which then reached only 50% of the max- 
imum histamine contraction even if given after an 
interval of 60 min, during which the tissue was 
repeatedly washed (not shown). 
Aminophylline at 5 x 10e4 M was only partially 
effective in causing relaxation of the histamine- 
induced contraction and was virtually ineffective 
against the PMA-induced contraction, having no 
effect at all in 4 of 11 experiments (figs 1 and 2b). 
Sodium nitroprusside, lo-’ M, had very little ef- 
fect on the histamine contraction but, unexpected- 
ly, exacerbated the PMA-induced contraction in 
all 9 experiments in which it was tested (figs 1 and 
2b): in one experiment by as much as 70%. 
The difference between the effect on the 
histamine-induced contraction and that on the 
PMA-induced contraction was statistically signifi- 
cant at the level p = 0.001, on Student’s t-test, for 
all ‘relaxants’ used. 
4. DISCUSSION 
It has recently been shown that when agonist ac- 
tion in vascular smooth muscle produces a sus- 
tained contraction, there is, concomitantly, a 
2-stage change in calcium concentration, con- 
sisting of an initial large calcium transient followed 
by a smaller maintained calcium response [lo]. 
Other results obtained [I 11 have given rise to the 
hypothesis that there are 2 calcium-dependent pro- 
cesses involved in vascular smooth muscle contrac- 
tion: an initial phosphorylation of myosin, 
necessary for force development, followed by a se- 
cond process which is necessary for force 
maintenance but which has a lower calcium re- 
quirement [ll]. Rasmussen et al. [7] have sug- 
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gested that protein kinase C may be involved in 
this second process in vascular smooth muscle. 
Protein kinase C has been shown to phosphorylate 
both smooth muscle heavy meromyosin [12] and 
myosin light chain kinase [13] the latter action 
resulting in a reduced affinity for 
Ca’+/calmodulin. 
Here we set out to see whether a protein kinase 
C-activator such as PMA would produce a tonic 
spasm in the smooth muscle of the lung paren- 
chymal strip, and if so, to compare the PMA 
response with the histamine response. We also 
wished to examine the effect of various agents 
known to relax smooth muscle, on both types of 
contraction. 
The results showed that PMA, lop5 M, caused a 
slowly-developing, sustained contraction of the 
parench~al strip. The smooth muscle in the strip 
is considered to be predominantly that of the 
smaller bronchioles and there is evidence from 
work on vascular tissue [7,8] that PMA is able to 
cause a similar slow contraction by a direct effect 
on smooth muscle itself. However, the lung paren- 
chymal strip is a complex tissue, cont~~ng many 
other types of cell, including mast cells, endothelial 
cells, leucocytes and platelets and it is known that 
PMA causes mediator release from many of these 
cells. Thus the contraction may have an indirect as 
well as a direct component. The contribution of 
these mediators, however, would seem to be of 
relatively minor importance since the contraction 
is maintained even after repeated, thorough 
washing of the tissue. 
The P-adrenoceptor agonist, isoprenaline, 
10e6 M, caused a marked relaxation of the 
histamine-Induced contraction but had only a 
minor effect on the PMA-induced contraction. p- 
Adrenoceptor-mediated relaxation is generally 
considered to be due to activation of adenylate 
cyclase resulting in increased cyclic AMP (review 
1141). There is evidence that the cyclic AMP- 
dependent kinase phosphorylates myosin light 
chain kinase apoenzyme and renders it less sen- 
sitive to activation by calcium/calmodulin [ 151, 
though other mechanisms for the relaxant effect of 
cyclic AMP on smooth muscle have been proposed 
1141. 
We thought it possible that the decreased effect 
of isoprenaline on the PMA- as compared with the 
histamine-induced contraction was due to a PMA- 
induced phosphorylation of the &receptor 
resulting in its desensitization [l&17]. We 
therefore expected that forskolin, a direct activator 
of adenylate cyclase, would be a more effective 
relaxant of the PMA-induced spasm than 
isoprenaline. Surprisingly, however, forskolin at a 
concentration of 10m6 M, which was approximate- 
ly equipotent with isoprenaline in relaxing the 
histamine contraction, was also only minimally ef- 
fective against the PMA spasm. The similarity in 
the actions of isoprenaline and forskolin on the ef- 
fects of both spasmogens was rather striking and 
suggested that desensitization of the @-receptor 
might not be involved in the reduced effect of 
isoprenaline on PMA spasm. 
Aminophylline was only moderately active in 
relaxing the histamine-induced contraction, and 
minim~ly active in relaxing the Pi-induced 
spasm, even when used in the high concentration 
of 5 x 10m4 M. Since this agent inhibits 
phosphodiesterase and results in an increase in 
cyclic AMP it was surprising that it was so much 
less effective than isoprenaline and forskolin. 
Sodium nitroprusside stimulates ~anylate 
cyclase and increases cyclic GMP, an action be- 
lieved to be the basis of the well-known relaxant ef- 
fect of sodium nitroprusside on vascular smooth 
muscle (reviews [18,19]). This agent, at a concen- 
tration of lo-> M has also been reported to cause 
marked relaxation (77%) of bovine tracheal mus- 
cle pre-contracted with carbachol [20]. It was 
unexpected therefore, to find that sodium 
nitroprusside had only a minimal relaxant effect 
on the guinea-pig lung parenchymal strip pre- 
contracted with histamine and that it actually in- 
creased the PMA-induced spasm of this tissue. 
Protein kinase C thus -appears to abrogate the 
relaxant action of smooth muscle guanylate 
cyclase, although it apparently enhances the activi- 
ty of the guanylate cyclase from rat brain [21]. 
These results may have relevance for the 
pathogenesis of asthma, and for the action of 
drugs used to treat asthma. Constriction of the 
bronchioles is responsible for the difficulty in 
breathing in the first phase of asthma. This con- 
striction is considered by most workers to be due 
largely to histamine and is rapidly reversed by p- 
adrenoceptor agonist drugs. A second, more severe 
increase in airways resistance, maximal 6-8 h after 
exposure to allergen, occurs frequently and is dif- 
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ficult to treat. The pathogenesis of this delayed 
phase, which is not adequately relieved by ,& 
adrenoceptor agonists, is not understood. We sug- 
gest that it is worth considering whether the 
phenomenon described here (protein kinase C- 
mediated spasm, relatively insusceptible to ,& 
agonists) might be implicated in the late phase of 
asthma, i.e. whether a tonic spasm produced by in- 
appropriately stimulated protein kinase C might 
contribute to this phase. In this context, it is of in- 
terest that the late phase of asthma can be 
prevented by prior administration of glucocor- 
ticoids: agents that direct the synthesis of a 
mediator protein, lipocortin, which, though 
primarily a phospholipase Aa inhibitor, also in- 
hibits phospholipase C [22] and thus could inhibit 
the generation of diacylglycerol (the endogenous 
protein kinase C activator) and prevent the tonic 
spasm which follows activation of this enzyme. 
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